Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Items for the Week

Ordered by most recent

U300 Insulin Glargine Produces Lower Rates of Night Time Hypoglycemia

A reduced risk of nocturnal hypoglycemia is among the advantages.... 


Diabetic Macular Edema (DME) Risk Higher for Non-Hispanic African American Patients

Risk is also higher for those who have had diabetes longer and have higher HbA1c levels.... 


Diet and Physical Activity Reduce Inflammatory Markers in Type 2

Both diet and diet plus physical activity interventions reduced inflammatory markers soon after type 2 diagnosis....



Sensor Implant Measures Blood pH in Type 1 Diabetes

The device, only tested in mice, also can release insulin to prevent acidosis.... 


CPAP Lowers BP and A1c in Patients with Obstructive Sleep Apnea and Type 2 Diabetes

Researchers also found that Quality of Life improved and costs were lowered.... 


Beta-Adrenergic Blockade Effects on Glucose Counterregulation in Advanced T2DM and Beta-Cell Failure

At normoglycemia, beta-adrenergic blockade may cause increased insulin sensitivity…. 


The Safety and Use of Oral Methazolamide in Type 2 Diabetes

Methazolamide, a carbonic anhydrase inhibitor, is a medication used to treat increased pressure inside the eye due to glaucoma.... 


Insulin Resistance's Effects on Tissue Iron Stores and Cognitive Performance

BIO (brain iron overload) could be a potentially useful MRI biomarker for insulin resistance and obesity-associated cognitive dysfunction.... 


Pistachios Associated with an Improved Metabolic Risk Profile in Prediabetes

In a study, patients who consumed pistachios showed improvement in fasting glucose, insulin, and HOMA of insulin resistance.... 


Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies

The glucose-reducing drug empagliflozin (Jardiance) now has approval from the FDA after the drug maker corrected manufacturing problems that caused the agency to say "no" in March....


Hypertension Control Can Prevent Renal Damage in Diabetics

Elevated blood pressure is associated with an increased risk of renal damage in patients with type 2 diabetes, especially if they have poor glycemic control.... 


New Way to Regenerate Beta Cells in Type 1 Diabetes

A peptide called caerulein can convert existing cells in the pancreas into insulin-generating beta cells....


CDC: 40% of American Adults Will Develop Diabetes

In Hispanic men and women, and non-Hispanic black women, the projected increased risk is even higher, over 50%....


Depressive Symptoms, Antidepressant Use, and Risk of Diabetes in African-American Women

Use of antidepressants was associated with a 26% higher risk of diabetes.... 


Printed Educational Messages to Promote Retinal Screening Not Effective

In a Canadian study, printed educational messages (PEMs) aimed at family practitioners were not effective in promoting retinal screening among diabetes patients....


Plasma Copeptin a Potential Marker for CVD in Asymptomatic T2DM Patients

Copeptin concentration also correlated to plasma creatinine and to PAD in T2DM patients.... 


A Novel Treatment for Type 2 Diabetes Patients

Tests in mice of recombinant human tissue kallikrein-1 show promise.... 


BG Levels during Acute Illness Can Help Predict Future Diabetes Risk

Blood glucose levels measured in hospitalized patients during acute illness predicted the risk of developing type 2 diabetes in the following three years.... 


New Ultra-Rapid-Acting Insulin Formulation

BIOD-531 is a new ultra-rapid-acting insulin formulation that has been shown to work better than current therapies at treating diabetes in a mid-stage trial.... 


Diabetic Neuropathy Improved with Vegan Diet

A randomized controlled trial indicates that a vegan diet may be beneficial in relieving diabetic nerve pain.... 


New Wearable Device Detects Diabetic Autonomic Neuropathy

Developed by Taiwanese researchers, the device can hang on a pair of glasses and is called a "pupillometer." ... 


Type 2 Diabetes Management More Difficult with Early Onset

Younger age groups may be at higher risk in developing complications, possibly due to later addition of statin medications….


Correlation between Insulin Sensitivity and Renal Problems

Renal abnormalities may be indicated by a specific key marker in type 2 diabetes.... 


Some Saturated Fats Can Protect against Diabetes

Not all saturated fatty acids are the same in relation to type 2 diabetes risk....


FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)

The US Food and Drug Administration has approved Invokamet, a fixed-dose therapy combining Invokana (canagliflozin) and metformin.... 


Should Non-diabetics Use Diabetes Drugs?

A study involving over 180,000 people showed that patients treated with metformin can live longer than non-diabetics.... 


The Importance of Control Solution

Control solution, used for ensuring the proper function of glucose meters, doesn't appear to be a priority among physicians, pharmacists, or patients.... 


Early Insulin Delays Diabetes But Are There Negative Consequences?

One researcher comments, "Please don't fall into this trap that you can prevent diabetes with insulin."…


Effects of Intensive Glycemic Control on Ischemic Heart Disease

How can three landmark trials of intensive vs standard glucose-lowering strategies -- ADVANCE, ACCORD, and VADT -- raise more questions than they answer?... 


Peripheral Neuropathy Associated with CV Disease and Stroke in Type 2 Diabetes Patients

Testing for peripheral neuropathy may provide a way to identify individuals at higher risk of cardiovascular events.... 


Dulaglutide vs. Exenatide as Add-On Therapy to Pioglitazone and Metformin in T2DM

Study seems to indicate superiority of dulaglutide, a long-acting GLP-1 receptor agonist that is administered once-weekly.... 


During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose

The effects of caffeine versus maltodextrin during exercise were observed in patients with type 2 diabetes.... 


A Link between Cesarean Delivery and Type 1 Diabetes?

Initial findings suggest relationship but with sibling-control analyses, effect almost disappears….


High BMI Can Improve GFR in Patients with Stage 3 or 4 CKD and Type 2 Diabetes

A BMI of more than 25 kg/m seems to be a protective factor for renal function deterioration in some patients.... 


Benefits of Tree Nuts in Glycemic Control

Displacement of high glycemic-index carbohydrates and high and monounsaturated fat content may explain the positive effects....


Amputation Rates Linked to Low-Income Neighborhoods in California

Rates for patients with diabetes are two times higher in low-income neighborhoods compared to high-income neighborhoods in California.... 


New Combination of Diabetes Drugs Have Synergistic Effect

Metformin and SGLT2 inhibitors together reduce the blood sugar levels of diabetics more effectively than either drug alone.... 


SGLT2 Inhibitor Empagliflozin Wins FDA OK

The glucose-reducing drug empagliflozin (Jardiance) won approval today from the US Food and Drug Administration (FDA) after Boehringer Ingelheim corrected manufacturing problems that caused the agency to say "no" in...


New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes

Beta cell encapsulation therapy is a procedure that involves implantation of cells with the ability to secrete insulin in a glucose-responsive manner in a protective barrier into the body....


Acarbose Treatment and the Reduction of CVD Risk in Type 2 Diabetes Patients

Previous studies have shown that decreasing postprandial hyperglycemia with acarbose could reduce the risk of CV events but a new study shows that risk may increase for the first 12 months of exposure…. 



Navigate through our listing of Items for the Week articles here.
Next Last

8851 Total articles for Items for the Week


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here

2014 Most Popular Articles:

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients
Posted August 01, 2014
New Combination of Diabetes Drugs Have Synergistic Effect
Posted August 08, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Posted August 08, 2014
Diabetic Neuropathy Improved with Vegan Diet
Posted August 22, 2014
During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose
Posted August 15, 2014
CDC: 40% of American Adults Will Develop Diabetes
Posted August 22, 2014
SGLT2 Inhibitor Empagliflozin Wins FDA OK
Posted August 08, 2014
HbA1c Increases with Age
Posted August 01, 2014
Early Insulin Delays Diabetes But Are There Negative Consequences?
Posted August 15, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
When Afrezza is available, will you prescribe it immediately or wait until it has been on the market for a while?
CME/CE of the Week
Peter Blume, DPM

Category: Wound Care
Credits: .5


Advertisement


Search Articles On Diabetes In Control